Clinical Trials Browser

OTHER × Epstein-Barr Virus Infections × Rituximab × Clear all

NCT04507477 2022-08-02

Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial

Phase 1/2 Unknown

Epstein-Barr Virus Infections

NCT01964755 2019-09-23

Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma

Phase 2 Terminated

6 enrolled 14 charts

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

NCT01058239 2018-02-15

Bortezomib Plus Rituximab for EBV+ PTLD

Phase 2 Completed

7 enrolled 15 charts

Epstein-Barr Virus Infections